l-2-Hydroxyglutarate remodeling of the epigenome and epitranscriptome creates a metabolic vulnerability in kidney cancer models.
Kundu A, Brinkley GJ, Nam H, Karki S, Kirkman R, Pandit M, Shim E, Widden H, Liu J, Heidarian Y, Mahmoudzadeh NH, Fitt AJ, Absher D, Ding HF, Crossman DK, Placzek WJ, Locasale JW, Rakheja D, McConathy JE, Ramachandran R, Bae S, Tennessen JM, Sudarshan S.
Kundu A, et al. Among authors: heidarian y.
J Clin Invest. 2024 May 14;134(13):e171294. doi: 10.1172/JCI171294.
J Clin Invest. 2024.
PMID: 38743486
Free PMC article.